Taaleri Bioindustry’s goal is to become a leader in the entire bioindustry ecosystem. Taaleri accelerates the global transition from a fossil economy towards a circular economy through our Bioindustry Fund I, co-investments and direct investments.
Taaleri Bioindustry is a forerunner and expert investing in the development and production of biobased materials on an industrial scale. Our portfolio covers scale-ups and industrial scale investments.
We have accumulated strong experience with investments in bioindustry over several years. Taaleri Bioindustry has a technically oriented and skilled investment team. Taaleri Bioindustry is one of the first private equity owner-operators in the Finnish bioindustry market.
Bioindustry means production utilising biobased materials or circular economy materials. Sustainable products replace products made from fossil or virgin raw materials. Taaleri invests in disruptive technologies and industrial-scale opportunities in bioindustry.
For example, Taaleri Bioindustry Fund I has invested in Enifer, a company producing mycoprotein. The fund has also invested in Nordic Bioproducts Group, a Finnish company producing cellulose-based materials.
Renewable resources have immense potential for replacing fossil-based materials and enabling a sustainable and circular economy where bioindustry investments act as the key enabler.
Taaleri Bioindustry aims to speed up this shift by enabling disruptive technologies to go to market, empowered by investment capital as well as strong expertise in new technologies and industry partnerships. Together with our investors, we are accelerating the global transition towards a more sustainable way of living.
Taaleri Bioindustry is part of the Taaleri Group. At the core of the Group’s strategy are the private equity fund business and substantial industrial investments, especially in bioindustry.
Taaleri Plc is listed on the Nasdaq Helsinki stock exchange.